nach oben

Reactions Weekly

Erschienen in:

01.03.2023 | Case report

Rituximab/tozinameran

Negative antibody response and vaccination failure: 2 case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Auszug

Author Information

An event is serious (based on the ICH definition) when the patient outcome is&colon;

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Furer V, et al. Immunogenicity induced by two and three doses of the BNT162b2 mRNA vaccine in patients with autoimmune inflammatory rheumatic diseases and immunocompetent controls: a longitudinal multicentre study. Annals of the Rheumatic Diseases 81 : 1594-1602, No. 11, Nov 2022. Available from: URL: http://doi.org/10.1136/ard-2022-222550

Titel: Rituximab/tozinameran
Negative antibody response and vaccination failure: 2 case report
Publikationsdatum: 01.03.2023
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-35941-2

Tozinameran

Case report

Mycophenolate-mofetil

Case report

Product information updates for donepezil, guanfacine and lisdexamfetamine

News item

Multiple drugs

Case report

Ad26.cov2-s/tozinameran

Case report

Alglucosidase-alfa

Case report

Springer Medizin

Rituximab/tozinameran

Negative antibody response and vaccination failure: 2 case report

Auszug

Weitere Artikel der Ausgabe 1/2023

Tozinameran

Mycophenolate-mofetil

Product information updates for donepezil, guanfacine and lisdexamfetamine

Multiple drugs

Ad26.cov2-s/tozinameran

Alglucosidase-alfa

Springer Medizin

Auszug

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Tozinameran

Mycophenolate-mofetil

Product information updates for donepezil, guanfacine and lisdexamfetamine

Multiple drugs

Ad26.cov2-s/tozinameran

Alglucosidase-alfa